VORICONAZOLE SANDOZ Voriconazole 200mg powder for injection vial

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

voriconazole, Quantity: 200 mg

Available from:

Sandoz Pty Ltd

INN (International Name):

Voriconazole

Pharmaceutical form:

Injection, powder for

Composition:

Excipient Ingredients: nitrogen; sulfobutyl betadex sodium

Administration route:

Intravenous Infusion

Units in package:

1 vial

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

VORICONAZOLE SANDOZ is indicated for treatment of the following fungal infections: -Invasive aspergillosis. -Serious Candida infections (including C. krusei), including oesophageal and systemic Candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). -Serious fungal infections caused by Scedosporium spp and Fusarium spp. -Other serious fungal infections, in patients intolerant of, or refractory to, other therapy. -Prophylaxis in patients who are at high risk of developing invasive fungal infections. The indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

Product summary:

Visual Identification: VORICONAZOLE SANDOZ powder for injection is a white lyophilised powder containing nominally 200 mg voriconazole; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2016-07-07